Health
Johnson & Johnson one-dose COVID-19 shot offers strong protection, fuels concern about variants – Firstpost
The vaccine’s efficacy rate dropped from 72 percent in the United States to just 57 percent in South Africa, where a highly contagious variant is driving most cases….
Unlike the messenger RNA vaccines made by Pfizer-BioNTech and Moderna, Johnson & Johnson uses an adenovirus, which normally causes the common cold. While adenovirus-based vaccines have been investigated for some three decades, they have yet to be licensed for use in the United States.
Johnson & Johnsons Ebola vaccine became the first approved adenovirus-based vaccine for any disease when European regulators gave it the green light last July. Astra-Zeneca and the University of Oxford used a different…
-
Noosa News20 hours agoBrisbane’s original 1979 electric trains take one last journey
-
General18 hours agoParis opens River Seine for public swimming for first time since 1923
-
Noosa News12 hours agoRainbow Beach surfer’s untold 7/7 story
-
Noosa News10 hours agoInfluenza cases nearly 20 per cent higher than 2024 as Queensland faces one of its worst flu seasons in years